Federation Des Caisses Desjardins Du Quebec Vera Therapeutics, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $23.7 Billion
- Q3 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 20 shares of VERA stock, worth $566. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 20
-0.0%
Holding current value
$566
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
201Shares Held
65.9MCall Options Held
128KPut Options Held
172K-
Avoro Capital Advisors LLC New York, NY6.21MShares$176 Million2.46% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.03MShares$114 Million9.86% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.67MShares$104 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.64MShares$103 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.57MShares$101 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $766M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...